SENORES — Senores Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹23.66bn
- IN₹26.24bn
- IN₹2.15bn
Annual cashflow statement for Senores Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 11.4 | 124 | 249 |
| Depreciation | |||
| Deferred Taxes | |||
| Non-Cash Items | -0.43 | 6.72 | 54.5 |
| Other Non-Cash Items | |||
| Changes in Working Capital | -123 | -160 | -604 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -104 | -10.8 | -199 |
| Capital Expenditures | -107 | -473 | -518 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | -138 | -10.1 | -28.3 |
| Acquisition of Business | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -244 | -483 | -547 |
| Financing Cash Flow Items | 211 | -14.1 | 213 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 365 | 463 | 870 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 15.8 | -31.1 | 125 |